Eupraxia Pharmaceuticals Inc
TSX:EPRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
CA |
|
Amcor PLC
ASX:AMCDD
|
CH |
|
M
|
Mentice AB
STO:MNTC
|
SE |
|
Subsea 7 SA
OSE:SUBC
|
UK |
|
F
|
F5 Inc
F:FFV
|
US |
|
Sotera Health Co
NASDAQ:SHC
|
US |
|
M
|
Mondi PLC
XMUN:KYC
|
UK |
|
Nomura Holdings Inc
TSE:8604
|
JP |
|
Altius Renewable Royalties Corp
F:7VZ
|
CA |
|
O
|
Osmosun SA
PAR:ALWTR
|
FR |
|
SEI Investments Co
NASDAQ:SEIC
|
US |
|
D
|
Desert Control AS
OSE:DSRT
|
NO |
|
Itesoft SA
PAR:ITE
|
FR |
|
Lundin Gold Inc
TSX:LUG
|
CA |
|
C
|
CNX Resources Corp
XBER:CGD
|
US |
|
W
|
Wharf Holdings Ltd
XMUN:WHA
|
HK |
|
Ferguson Enterprises Inc
NYSE:FERG
|
US |
|
Puma SE
F:PUMA
|
DE |
|
Camtek Ltd
F:CMZ
|
IL |
|
Cascades Inc
TSX:CAS
|
CA |
|
CLARIVATE PLC
NYSE:CLVT
|
UK |
|
G
|
Greatland Resources Ltd
SWB:U0Y
|
AU |
|
Mirait One Corp
F:5FO
|
JP |
|
Natera Inc
NASDAQ:NTRA
|
US |
Bankruptcy Probability
Eupraxia Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eupraxia Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
499.8m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
150.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eupraxia Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eupraxia Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
